Pharma Fusion Board of Directors Announces Strategic Initiative to Establish National Center of Excellence in Immunoglobulin (IG) Therapy

LAKE CHARLES, LA / ACCESS Newswire / April 14, 2026 / Pharma Fusion, a premier national specialty pharmacy organization, today announced that its Board of Directors has unanimously approved a landmark initiative to position the Pharma Fusion brand as a National Center of Excellence in Immunoglobulin (IG) Therapy. This strategic designation marks a pivotal advancement in the company's mission to elevate standards of clinical precision and patient safety, anchored by the gold benchmarks of ACHC and URAC accreditation.

By achieving Center of Excellence status, Pharma Fusion is formalizing one of the industry's most sophisticated treatment models for both Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) therapies. It is estimated that approximately 275,000 patients in the US are treated with IVIG or SCIG therapies annually for a broad spectrum of rare and chronic conditions. This initiative will harness the organization's proprietary Specialty Intelligence™ framework to optimize care for patients living with primary immunodeficiencies, autoimmune conditions, and complex rare neurological disorders.

"Our Board's commitment to becoming a true Center of Excellence is far more than an organizational milestone - it is a declaration of clinical rigor," said Dr. Sajal Roy, Chairman of the Board, PharmD, CSP, CGP, IgCP. "By aligning every facet of our operations with ACHC and URAC standards, Pharma Fusion ensures that each patient receiving IG therapy is supported by uncompromising safety, data-driven oversight, and a depth of expertise rarely found in the specialty pharmacy landscape."

Clinical Excellence Through Advanced Credentials is central to this designation and reinforces Pharma Fusion's commitment to expanding a highly specialized clinical workforce. The company proudly highlights their elite cadre of Certified Specialty Pharmacists (CSP®), a credential signifying a mastery of complex specialty therapeutics, and a rigorously trained team of Immunoglobulin Certified Pharmacists (IgCP®). This dual-tier credentialing underscores the organization's dedication to clinical sophistication in every phase of IG therapy, from dosing and side-effect management to ongoing site-of-care optimization.

A Commitment to Elevating Quality Standards Pharma Fusion's adherence to URAC and ACHC standards provides a nationally recognized framework for continuous quality and transparent accountability. These accreditations validate a pharmacy's excellence in: •

• Patient Safety & Clinical Oversight: Rigorous therapeutic monitoring, proactive clinical conversation that elevate medication adherence and tolerance.

• Operational Integrity: Maintaining the concierge-level service across all 50 states including US territories.

• Risk Management: Ensuring unyielding standards in biologic handling.

"We are breaking down the geographic and administrative barriers that too often stand between patients and the specialized IG therapy they require to live an active life. Our pharmacists' holding the highest credentials empower us to deliver the most personalized, data-informed treatments available that improve real-world outcomes; not only for patients but for clinicians, payers, and manufacturers alike," said Nicholas Self, Chief Operations Officer.

About Pharma Fusion

Pharma Fusion is a leading specialty pharmacy committed to advancing care for patients with rare and complex conditions. Through its Specialty Intelligence™ model, the organization integrates clinical expertise, proactive care coordination, and data-driven insights to deliver exceptional outcomes for patients, providers, manufacturers and healthcare partners across the United States.

Visit www.pharmafusionrx.com or connect with Pharma Fusion on Linkedin and Facebook.

About ACHC

ACHC is widely recognized for its collaborative and educational approach to accreditation, offering a suite of pharmacy-specific programs that include Specialty, Infusion, and Long-Term Care. By maintaining ISO 9001:2015 certification, ACHC ensures that its own quality management systems meet international standards, which translates into a rigorous yet fair survey process for providers. Their focus on "The ACHC Way" prioritizes a consultative relationship, helping pharmacies not only meet industry benchmarks for patient safety and operational efficiency but also foster a culture of continuous improvement that enhances long-term clinical outcomes.

Visit www.achc.org for more details.

About URAC

As a leader in health care quality, URAC sets a high bar for excellence through a collaborative and flexible accreditation process that empowers organizations to innovate without being prescriptive. By focusing on a "Gold Star" standard of excellence, URAC helps pharmacies manage complex medication therapies with the highest levels of clinical oversight and consumer protection while allowing them to develop their own unique policies and procedures. Achieving URAC accreditation is an independent validation that goes beyond a mere "rubber stamp," serving as a public symbol of a pharmacy's commitment to continuous improvement, risk management, and superior clinical outcomes. This recognition is often a critical differentiator for securing contracts, as it provides payers, partners, and patients with documented proof that an organization adheres to the most stringent national standards for safety and quality.

Visit www.urac.org for more details

Media Contact:

Caitlin Henderson
510-407-5561

SOURCE: Pharma Fusion